Listening across frequencies: Capturing seizures of all patients to advance antiseizure medication development

The paper critiques the traditional requirement of ≥4 seizures per month for epilepsy trial enrollment, noting this threshold excludes many patients as improved treatments have reduced baseline seizure burden. The authors propose alternative time-to-event trial designs that enable broader patient inclusion while maintaining rigor, alongside integration of cognitive outcome measures alongside seizure control assessments.